GlassScriptPhysician profile
Piyush Mittal
NPI 1447250923
$9,264.43
in general payments reported to CMS, 2019-2025
50 companies · $887 in 2025
The $887 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $1,169 · 2021: $1,787 · 2022: $1,971 · 2023: $1,323 · 2024: $1,550 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,759.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,041.53 | 2019-2025 | Repatha, Evenity, Otezla |
| Abbvie INC. | $821.90 | 2020-2025 | |
| Novo Nordisk INC | $681.19 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $636.29 | 2019-2024 | |
| Abbott Laboratories | $583.48 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $530.59 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Radius Health, INC. | $458.71 | 2019-2025 | Tymlos |
| Mylan Specialty L.P. | $456.07 | 2019-2023 | Yupelri |
| Janssen Pharmaceuticals, INC | $367.64 | 2019-2022 | |
| Astellas Pharma US INC | $315.42 | 2019-2021 | |
| Glaxosmithkline, LLC. | $265.63 | 2019-2023 | Trelegy Ellipta, Shingrix |
| Allergan, INC. | $262.16 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $248.77 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $246.29 | 2021-2025 | Gattex, Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.98 | 2021-2024 | Tradjenta, Jardiance, Synjardy |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Piyush Mittal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.